首页> 外国专利> METHOD FOR DETERMINING THE GENETIC PREDISPOSITION TO THE DEVELOPMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS MYCOBACTERIUM TUBERCULOSIS IN HIV INFECTION

METHOD FOR DETERMINING THE GENETIC PREDISPOSITION TO THE DEVELOPMENT OF MULTIDRUG-RESISTANT TUBERCULOSIS MYCOBACTERIUM TUBERCULOSIS IN HIV INFECTION

机译:确定艾滋病毒感染致致抗性结核分枝杆菌结核分枝杆菌的发展遗传易感性的方法

摘要

FIELD: medicine, infectious diseases in particular. ;SUBSTANCE: invention relates to the field of medicine, in particular to infectious diseases, phthisiology and therapy. A method for determining the genetic predisposition to the development of multidrug-resistant tuberculosis Mycobacterium tuberculosis is proposed. In patients at risk, venous blood samples are collected, genomic DNA is isolated, and an allele-specific polymerase chain reaction is performed to genotype the arylamine acetyltransferase 2 NAT2 gene at polymorphic loci rs1208, rs1799930, and rs1799929. Carriers of the combination of genotypes NAT2Lys268Lys А803А × NAT2Arg197Arg G590G × NAT2Leu161Leu С481С are predicted to develop multidrug-resistant tuberculosis Mycobacterium tuberculosis with a 10.775-fold risk. EFFECT: invention makes it possible to predict the development of multidrug-resistant tuberculosis Mycobacterium tuberculosis in HIV patients and to adjust the therapeutic tactics of managing patients at the stage of prescribing medicines. ;2 cl, 2 tbl, 3 ex
机译:田地:特别是医学,传染病。 ;物质:发明涉及医学领域,特别是传染病,耳瘤和治疗。提出了一种确定遗传性易于发展结核分枝杆菌结核分枝杆菌的遗传倾向的方法。在风险的患者中,收集静脉血液样品,分离基因组DNA,并在多晶型基因座RS1208,RS1799930和RS1799999999999中进行等位基因特异性聚合酶链反应对芳基胺乙酰转移酶2 NAT2基因进行基因键键。基因型NAT2 Lys268lys的组合载体а803А×NAT2 arg197arg G590g ×NAT2 Leu161LeС481С以开发多药结核分枝杆菌结核分枝杆菌风险10.775倍。效果:发明使得可以预测HIV患者中多药抗性结核分枝杆菌结核分枝杆菌的发育,并在处方药物阶段调整管理患者的治疗策略。 ; 2 cl,2 tbl,3前

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号